Table 2 Age-adjusted characteristics of Health Professionals Follow-up Study participants with nonmetastatic PCa, according to extreme categories of first health behaviour scores following diagnosis.

Sample size:	2021 PCa Behaviour Score, n = 4968		2015 PCa Behaviour Score, n = 4605		WCRF/AICR Score, n = 5223		ACS Score, n = 5208
# Points:	0–1	3	0–1	5–6	0–2.5	5.25–7	0–1.5	5–6
n	423	1170	173	645	635	609	568	705
Mean age at diagnosis, years ± SD	69 ± 6.7	70 ± 7.0	69 ± 6.7	69 ± 6.8	69 ± 7.4	70 ± 6.7	70 ± 6.7	69 ± 6.8
Age at diagnosis, %
<65	30	23	25	28	26	22	23	26
65–69	28	26	35	26	28	29	30	26
70–74	22	26	24	27	23	27	26	27
75–79	15	18	13	14	15	16	15	15
≥80	5.2	6.8	2.9	5.0	7.4	6.2	6.0	5.3
Stage at diagnosis, %
T1/N0/M0	57	61	58	66	65	57	62	63
T2/N0/M0	42	37	41	31	34	40	36	35
T3a/N0/M0	1.4	1.9	1.7	2.4	1.5	2.4	2.1	2.0
Gleason score at diagnosis^a, %
<7	55	60	60	59	62	59	58	58
7	31	30	26	31	26	31	29	32
>7	14	9.6	15	9.9	11	11	12	10
Median PSA at diagnosis^a, ng/mL (IQR)	7.0 (4.7, 11)	6.6 (4.8, 10)	7.0 (4.9, 10)	6.0 (4.6, 9.2)	6.5 (4.7, 9.8)	6.4 (4.6, 9.7)	7.0 (4.9, 10)	6.3 (4.7, 9.1)
PSA at diagnosis^a, %
≤6	40	43	40	50	46	46	40	46
>6–10	31	32	37	28	31	32	34	33
>10–20	18	19	11	16	16	17	18	15
>20	11	5.7	12	6.2	7.4	6.2	8.3	5.5
Primary treatment^a, %
Radical prostatectomy	40	52	43	43	43	48	43	50
Radiation	40	34	43	42	42	35	43	36
Hormone therapy	9.8	4.1	7.3	3.3	4.8	6.0	6.0	3.6
Watchful waiting	7.1	8.1	3.8	9.9	7.5	8.9	6.2	8.7
Other	3.3	1.6	2.5	1.6	2.4	1.7	1.7	1.4
Year of diagnosis, %
1994 or earlier	23	23	25	17	16	25	18	17
1995–1999	22	21	18	21	24	20	23	21
2000–2004	27	23	29	26	28	25	30	23
2005–2009	21	24	20	25	24	19	20	26
2010 or later	7.5	9.3	6.8	11	7.8	12	8.4	13
Non-Hispanic White, %	95	97	95	97	96	95	97	97
Family history of PCa, %	11	18	18	17	15	17	14	17

Notes: all values calculated based on individuals without missing data; percentages may not add up as expected due to rounding.
ACS American Cancer Society, AICR American Institute for Cancer Research, IQR interquartile range, PCa prostate cancer, PSA prostate-specific antigen, SD standard deviation, WCRF World Cancer Research Fund.
^aAmong individuals with information available.

Search